Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,151,218 papers from all fields of science
Search
Sign In
Create Free Account
recurrent plasma cell neoplasm
Known as:
Recurrent Multiple Myeloma
, Recurrent Plasma Cell Myeloma
, plasma cell neoplasm, recurrent
The reemergence of plasma cell myeloma after a period of remission.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
36 relations
Anemia
Atypical lymphocyte
B lymphoblast
B-Lymphocytes
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Case of HIV positive multiple solitary recurrent extra medullary plasmacytoma
P. Jadhav
2014
Corpus ID: 74478680
Objective - HIV is known to increase the chances of occurrence of B-cell neoplasms. There have been citations of cases of primary…
Expand
2012
2012
Intraoperative cytopathological diagnosis of plasmocytoma of the optic nerve head using fine-needle aspiration
J. L. Salazar-Diez
,
D. Iturralde
,
D. Rodríguez-Feijoo
,
Marta Usabiaga
Graefe's Archive for Clinical and Experimental…
2012
Corpus ID: 43516219
2010
2010
[Effectiveness of bortezomib and bortezomib-containing programs for the treatment of recurrent and resistant multiple myeloma].
T. Mitina
,
A. Golenkov
,
E. Kataeva
,
T. D. Lutskaia
,
E. Trifonova
,
E. Klinushkina
Терапевтический архив
2010
Corpus ID: 31534254
AIM To evaluate the effectiveness of bortezomib and bortezomib-containing treatment programs in the therapy of resistant and…
Expand
2009
2009
[Pharmacodynamic characteristics of velcade efficacy in resistant and recurrent multiple myeloma: determination of free light chains of blood serum immunoglobulins].
A. Golenkov
,
T. Mitina
,
I. Kogarko
,
N. Liubimova
,
E. Klinushkina
,
A. Baryshnikov
Терапевтический архив
2009
Corpus ID: 33112007
AIM To ascertain individual sensitivity to velkeid in patients with resistant and recurrent multiple myeloma (MM) by…
Expand
2008
2008
[Clinical characteristics of velcade cumulative effect in resistant and recurrent multiple myeloma].
T. Mitina
,
A. Golenkov
Терапевтический архив
2008
Corpus ID: 25020753
AIM To assess efficacy of velcade monotherapy in patients with resistent and recurrent multiple myeloma (MM). MATERIAL AND…
Expand
2005
2005
Phase I trial of a humanized anti-CD40 monoclonal antibody (SGN-40) in the treatment of multiple myeloma
M. Hussein
,
J. Berenson
,
+7 authors
M. Mcdonald
2005
Corpus ID: 68891585
6581 Background: CD40 is a member of the Tumor Necrosis Factor (TNF) family of receptors and is expressed on the surface of B…
Expand
1999
1999
Donor leukocyte infusions inducing remissions repeatedly in a patient with recurrent multiple myeloma after allogeneic bone marrow transplantation
R. V. D. Griend
,
L. Verdonck
,
E. Petersen
,
P. Veenhuizen
,
A. Bloem
,
H. Lokhorst
Bone Marrow Transplantation
1999
Corpus ID: 32983989
We describe a patient with recurrent relapses after allogeneic BMT for multiple myeloma who repeatedly went into CR after donor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required